Consistent with this, high serum concentrations of shed MICA are associated with disease progression in many human cancers, including melanoma [35], where vemurafenib and histone deacetylase inhibitors (such as sodium butyrate) differentially modulate expression of NKG2D ligands such as MICA [36]. This evidence concerns the gene KLRK1 and melanoma.